Fostering a sea-change in pharmaceutical development

South Africa’s huge disease burden continues to be of great concern to the government and any efforts to address the situation are good news. For that reason, the new ground being broken in the study of marine microbial organisms as a means of discovering pharmaceuticals for a range of diseases, in particular viral infections such as HIV/Aids, is welcome.

This work is the focus of Professor Rosemary Dorrington at Rhodes University in the Research Chair in Marine Natural Products Research, which she occupied this year.

Her research is closely linked to the search for next generation pharmaceuticals based on the unique properties of microbial symbionts associated with indigenous marine sponges and other invertebrates. Marine organisms are recognised as an important source of new bioactive compounds with potential pharmaceutical and other economically important applications.

The scope of pharmaceutical application is broad, with discoveries pointing to the potential to produce drugs for the treatment of cancers and to use as antibiotics for the treatment of bacterial pathogens and malaria.

The Chair is highly multidisciplinary in nature, involving the fields of chemistry, marine biology, geography and microbiology, which she says is crucial to expanding knowledge across these various groups.


She adds that South Africa is in a unique position to capitalise on its rich marine biodiversity, much of which is still unexplored. Her research group is therefore involved in the exploration of the country’s coastline (from Algoa Bay to De Hoop near Cape Agulhas) for marine organisms that can unlock new knowledge.

Her multidisciplinary approach is important in developing expertise in this field across the different disciplines. She says the country will benefit tremendously from having, for example, chemists with an understanding of molecular biology and biologists who have chemistry skills.

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Advertorial
Guest Author

Related stories

Advertising

Subscribers only

How lottery execs received dubious payments through a private company

The National Lottery Commission is being investigated by the SIU for alleged corruption and maladministration, including suspicious payments made to senior NLC employees between 2016 and 2017

Pandemic hobbles learners’ futures

South African schools have yet to open for the 2021 academic year and experts are sounding the alarm over lost learning time, especially in the crucial grades one and 12

More top stories

Egypt, Seychelles get first jabs

The two countries have rolled out China’s Sinopharm vaccine, but data issues are likely to keep some countries from doing the same

Fashion’s future is bricks and clicks

Lockdown forced reluctant South African clothing retail stores online: although foot traffic in brick-and-mortar stores remains important in a mall culture like ours, the secret to success is innovation

What the Biden presidency may mean for Africa

The new US administration has an interest and much expertise in Africa. But given the scale of the priorities the administration faces, Africa must not expect to feature too prominently

Zuma, Zondo play the waiting game

The former president says he will talk once the courts have ruled, but the head of the state capture inquiry appears resigned to letting the clock run out as the commission's deadline nears
Advertising

press releases

Loading latest Press Releases…